Immune or inherited thrombocytopenia? A population-based cohort study on children and adolescents presenting with a low platelet count

IF 2.4 3区 医学 Q2 HEMATOLOGY Pediatric Blood & Cancer Pub Date : 2024-10-04 DOI:10.1002/pbc.31363
Lauri-Matti Kulmala, Henri Aarnivala, Tytti Pokka, Anu Huurre, Liisa Järvelä, Sauli Palmu, Tuuli Pöyhönen, Riitta Niinimäki
{"title":"Immune or inherited thrombocytopenia? A population-based cohort study on children and adolescents presenting with a low platelet count","authors":"Lauri-Matti Kulmala,&nbsp;Henri Aarnivala,&nbsp;Tytti Pokka,&nbsp;Anu Huurre,&nbsp;Liisa Järvelä,&nbsp;Sauli Palmu,&nbsp;Tuuli Pöyhönen,&nbsp;Riitta Niinimäki","doi":"10.1002/pbc.31363","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Thrombocytopenia is a common hematologic finding in children and adolescents. Immune thrombocytopenia (ITP) is the most common cause of this finding, but the differential diagnosis includes a growing list of genetic disorders. We aimed to report differences in phenotypes of patients with ITP, inherited platelet disorder (IPD)/primary immunodeficiency disorder (PID), and other causes, with a focus on differentiating ITP from inherited thrombocytopenia.</p>\n </section>\n \n <section>\n \n <h3> Procedure</h3>\n \n <p>This retrospective, population-based observational cohort from 2006 to 2020 involved 506 Finnish children under 16 years of age presenting with isolated thrombocytopenia.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Of the 506 participants, 79.7% had ITP, 6.7% had IPD/PID, and 13.6% had other causes of thrombocytopenia. A platelet count of ≤12 × 10<sup>9</sup>/L best distinguished between ITP and other reasons with a sensitivity of 60% and a specificity of 80%. Among patients with the lowest platelet count of less than 10 × 10<sup>9</sup>/L, 95.9% had ITP, 3.3% had IPD/PID, and 0.8% had other causes. Severe bleeding events were reported in 20 patients (4.0%), but there were no cases of intracranial or fatal bleeding due to thrombocytopenia. Up to 50% of patients with a high suspicion of inherited thrombocytopenia remained without a specific diagnosis despite genetic testing.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>ITP remains the most common cause of thrombocytopenia. A platelet count of ≤12 × 10<sup>9</sup>/L often leads to an ITP diagnosis. Genetic disorders are rare but should be suspected in patients with persisting thrombocytopenia, especially with platelet counts constantly above 12 × 10<sup>9</sup>/L, a positive family history, or atypical clinical features.</p>\n </section>\n </div>","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":"71 12","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/pbc.31363","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Blood & Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pbc.31363","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Thrombocytopenia is a common hematologic finding in children and adolescents. Immune thrombocytopenia (ITP) is the most common cause of this finding, but the differential diagnosis includes a growing list of genetic disorders. We aimed to report differences in phenotypes of patients with ITP, inherited platelet disorder (IPD)/primary immunodeficiency disorder (PID), and other causes, with a focus on differentiating ITP from inherited thrombocytopenia.

Procedure

This retrospective, population-based observational cohort from 2006 to 2020 involved 506 Finnish children under 16 years of age presenting with isolated thrombocytopenia.

Results

Of the 506 participants, 79.7% had ITP, 6.7% had IPD/PID, and 13.6% had other causes of thrombocytopenia. A platelet count of ≤12 × 109/L best distinguished between ITP and other reasons with a sensitivity of 60% and a specificity of 80%. Among patients with the lowest platelet count of less than 10 × 109/L, 95.9% had ITP, 3.3% had IPD/PID, and 0.8% had other causes. Severe bleeding events were reported in 20 patients (4.0%), but there were no cases of intracranial or fatal bleeding due to thrombocytopenia. Up to 50% of patients with a high suspicion of inherited thrombocytopenia remained without a specific diagnosis despite genetic testing.

Conclusions

ITP remains the most common cause of thrombocytopenia. A platelet count of ≤12 × 109/L often leads to an ITP diagnosis. Genetic disorders are rare but should be suspected in patients with persisting thrombocytopenia, especially with platelet counts constantly above 12 × 109/L, a positive family history, or atypical clinical features.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
免疫性还是遗传性血小板减少症?一项针对血小板计数低的儿童和青少年的人群队列研究。
背景:血小板减少是儿童和青少年常见的血液学症状。免疫性血小板减少症(ITP)是导致这一结果的最常见原因,但鉴别诊断包括越来越多的遗传性疾病。我们旨在报告免疫性血小板减少症、遗传性血小板减少症(IPD)/原发性免疫缺陷症(PID)和其他病因患者的表型差异,重点是区分免疫性血小板减少症和遗传性血小板减少症:2006年至2020年,506名16岁以下的芬兰儿童因孤立性血小板减少症接受了基于人群的回顾性队列观察:在506名参与者中,79.7%患有ITP,6.7%患有IPD/PID,13.6%患有其他原因引起的血小板减少症。血小板计数≤12 × 109/L最能区分ITP和其他原因,敏感性为60%,特异性为80%。在血小板最低计数低于 10 × 109/L 的患者中,95.9% 患有 ITP,3.3% 患有 IPD/PID,0.8% 患有其他原因。据报告,20 名患者(4.0%)发生了严重出血事件,但没有因血小板减少而导致颅内出血或致命出血的病例。在高度怀疑患有遗传性血小板减少症的患者中,多达50%的患者尽管接受了基因检测,但仍未得到明确诊断:结论:ITP仍是血小板减少症最常见的病因。血小板计数≤12 × 109/L通常可诊断为ITP。遗传性疾病很少见,但对于持续血小板减少的患者,尤其是血小板计数持续高于 12 × 109/L、有阳性家族史或临床特征不典型的患者,应怀疑遗传性疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Pediatric Blood & Cancer
Pediatric Blood & Cancer 医学-小儿科
CiteScore
4.90
自引率
9.40%
发文量
546
审稿时长
1.5 months
期刊介绍: Pediatric Blood & Cancer publishes the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.
期刊最新文献
Hypoalbuminemia and Nutritional Status in Children with Cancer. Systemic Inflammatory Response Post Alemtuzumab and Low-Dose Total Body Irradiation in Pediatric Patients With Sickle Cell Disease: A Case Series. Implications of Implementing Children's Oncology Group Risk Stratification to Patients With Rhabdomyosarcoma Treated on European Paediatric Soft Tissue Sarcoma Study Group Clinical Trial. A Rare t(X;21)(p11;q22) in Childhood Acute Myeloid Leukemia: Case Report and Literature Review. Centralized Investigator Review of Radiological and Functional Imaging Reports in Real-World Oncology Studies: The SACHA-France Experience.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1